Serralase Enzyme Supplements; Packaged in 90 and 180 tablet bottled
Recalling firm: ProThera, Inc.
ProThera was notified by enzymes provided by Specialty Enzymes within the last 3-6 months may be contaminated with chloramphenicol.
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Feb 24, 2014.
Check your package
Compare the exact product and package details with the label you have.
FDA code information
Lot F3994
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Serralase Enzyme Supplements; Packaged in 90 and 180 tablet bottled UPC - 90 count: 8 28054 00542 6 UPC- 180 count 8 28054 00149 7; Manufactured by: ProThera, Inc., Reno, NV 89521
Original FDA recall reason
ProThera was notified by enzymes provided by Specialty Enzymes within the last 3-6 months may be contaminated with chloramphenicol.
Recall details
- Recall number
- F-0158-2014
- Event ID
- 66553
- FDA status
- Terminated
- Initiated
- Oct 10, 2013
- Reported
- Nov 20, 2013
- Classified
- Nov 12, 2013
- Terminated
- Feb 24, 2014
- Quantity
- 27,480
- Location
- Reno, NV, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Letter
Where it was distributed
US and Australia, Azerbaijan, Brazil, Canada, Germany, Great Britain, Hong Kong, Ireland (Eire, Japan, Malaysia, Malta, Mexico, New Zealand, Panama, Philippines, Russia, South Korea, Spain, Switzerland, Thailand.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.